Page last updated: 2024-10-29

ketamine and Infant, Newborn, Diseases

ketamine has been researched along with Infant, Newborn, Diseases in 5 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research Excerpts

ExcerptRelevanceReference
"Ketamine is an N-methyl-d-aspartate (NMDA) receptor antagonist that works by binding to the phencyclidine-binding site, thereby blocking influx of cations through the NMDA receptor channel."2.66Are Ketamine Infusions a Viable Therapeutic Option for Refractory Neonatal Seizures? ( Bingham, W; Huntsman, RJ; Strueby, L, 2020)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Huntsman, RJ1
Strueby, L1
Bingham, W1
Samanta, D1
Minnigerode, B1
Meissner, R1
Caspary, F1
Mendenhall, MK1
Ahlgren, EW1
Janis, KM1
Wright, W1

Reviews

1 review available for ketamine and Infant, Newborn, Diseases

ArticleYear
Are Ketamine Infusions a Viable Therapeutic Option for Refractory Neonatal Seizures?
    Pediatric neurology, 2020, Volume: 103

    Topics: Drug Resistant Epilepsy; Excitatory Amino Acid Antagonists; Humans; Infant, Newborn; Infant, Newborn

2020

Other Studies

4 other studies available for ketamine and Infant, Newborn, Diseases

ArticleYear
Ketamine in Refractory Neonatal Seizures.
    Pediatric neurology, 2020, Volume: 106

    Topics: Epilepsy; Humans; Infant, Newborn; Infant, Newborn, Diseases; Ketamine; Seizures; Status Epilepticus

2020
[5-years of experience with tranquilizing-analgesics in laryngo-tracheo-bronchoscopic procedures in newborns and infants ].
    Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood, 1982, Volume: 36, Issue:2

    Topics: Analgesia; Bronchial Diseases; Bronchoscopy; Diazepam; Humans; Infant; Infant, Newborn; Infant, Newb

1982
Anesthetic considerations in surgery for gastrointestinal disease.
    The Surgical clinics of North America, 1979, Volume: 59, Issue:5

    Topics: Aged; Anesthetics; Drug Interactions; Enflurane; Female; Gastrointestinal Diseases; Halothane; Human

1979
Failure to produce analgesia with ketamine in two patients with cortical disease.
    Anesthesiology, 1972, Volume: 36, Issue:4

    Topics: Analgesia; Anesthetics; Brain; Brain Diseases; Cyclohexanes; Humans; Infant, Newborn; Infant, Newbor

1972